| Recent advances in iron complexes as potential anticancer agents WA Wani, U Baig, S Shreaz, RA Shiekh, PF Iqbal, E Jameel, A Ahmad, ... New Journal of Chemistry 40 (2), 1063-1090, 2016 | 184 | 2016 |
| Ferroquine and its derivatives: new generation of antimalarial agents WA Wani, E Jameel, U Baig, S Mumtazuddin, LT Hun European journal of medicinal chemistry 101, 534-551, 2015 | 162 | 2015 |
| Coumarin: a privileged scaffold for the design and development of antineurodegenerative agents E Jameel, T Umar, J Kumar, N Hoda Chemical biology & drug design 87 (1), 21-38, 2016 | 151 | 2016 |
| Rational design, synthesis and biological screening of triazine-triazolopyrimidine hybrids as multitarget anti-Alzheimer agents E Jameel, P Meena, M Maqbool, J Kumar, W Ahmed, S Mumtazuddin, ... European journal of medicinal chemistry 136, 36-51, 2017 | 91 | 2017 |
| Curcumin specifically binds to the human calcium–calmodulin-dependent protein kinase IV: Fluorescence and molecular dynamics simulation studies N Hoda, H Naz, E Jameel, A Shandilya, S Dey, MI Hassan, F Ahmad, ... Journal of Biomolecular Structure and Dynamics 34 (3), 572-584, 2016 | 81 | 2016 |
| Synthesis and screening of triazolopyrimidine scaffold as multi-functional agents for Alzheimer's disease therapies J Kumar, P Meena, A Singh, E Jameel, M Maqbool, M Mobashir, ... European Journal of Medicinal Chemistry 119, 260-277, 2016 | 78 | 2016 |
| Development of cyanopyridine–triazine hybrids as lead multitarget anti-Alzheimer agents M Maqbool, A Manral, E Jameel, J Kumar, V Saini, A Shandilya, M Tiwari, ... Bioorganic & medicinal chemistry 24 (12), 2777-2788, 2016 | 63 | 2016 |
| Pyrimidine‐Triazolopyrimidine and Pyrimidine‐Pyridine Hybrids as Potential Acetylcholinesterase Inhibitors for Alzheimer's Disease J Kumar, A Gill, M Shaikh, A Singh, A Shandilya, E Jameel, N Sharma, ... ChemistrySelect 3 (2), 736-747, 2018 | 46 | 2018 |
| Structure guided design of potential inhibitors of human calcium–calmodulin dependent protein kinase IV containing pyrimidine scaffold H Naz, E Jameel, N Hoda, A Shandilya, P Khan, A Islam, F Ahmad, ... Bioorganic & Medicinal Chemistry Letters 26 (3), 782-788, 2016 | 39 | 2016 |
| Design, synthesis, and biological evaluation of pyrimidine derivatives as potential inhibitors of human calcium/calmodulin‐dependent protein kinase IV E Jameel, H Naz, P Khan, M Tarique, J Kumar, S Mumtazuddin, ... Chemical biology & drug design 89 (5), 741-754, 2017 | 32 | 2017 |
| Recent advancements in chromone as a privileged scaffold towards the development of small molecules for neurodegenerative therapeutics H Madhav, E Jameel, M Rehan, N Hoda RSC Medicinal Chemistry 13 (3), 258-279, 2022 | 31 | 2022 |
| Catalytic Atroposelective Dynamic Kinetic Resolution of Biaryl Lactones with Activated Isocyanides JYL Linghui Qian, Ling-Fei Tao, Wen-Tao Wang, Ehtesham Jameel, Zhang-Hong ... Organic Letters, 2021 | 27 | 2021 |
| De novo lead optimization of triazine derivatives identifies potent antimalarials A Shandilya, N Hoda, S Khan, E Jameel, J Kumar, B Jayaram Journal of Molecular Graphics and Modelling 71, 96-103, 2017 | 10 | 2017 |
| Identification of new oxospiro chromane quinoline-carboxylate antimalarials that arrest parasite growth at ring stage E Jameel, H Madhav, P Agrawal, MK Raza, S Ahmedi, A Rahman, ... Journal of Biomolecular Structure and Dynamics 41 (24), 15485-15506, 2023 | 3 | 2023 |
| Reinvestigation of diphenylmethylpiperazine analogues of pyrazine as new class of Plasmodial cysteine protease inhibitors for the treatment of malaria H Madhav, GS Reddy, Z Rizvi, E Jameel, TS Patel, A Rahman, V Yadav, ... RSC Medicinal Chemistry 15 (3), 1022-1037, 2024 | 1 | 2024 |
| Ivermectin as a Repurposed Drug for COVID‐19 H Madhav, M Rehan, N Hoda, E Jameel Chemistry and Biological Activities of Ivermectin, 47-68, 2023 | | 2023 |
Nasimul HodaProfessor, Department of Chemistry, Jamai Millia Islamia, New Delhi-110025, India.Email confirmado em jmi.ac.in